EMFAT
PASG icon

Emerald Mutual Fund Advisers Trust’s Passage Bio PASG Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-14,511
Closed -$3.84M – 230
2021
Q2 		$3.84M Sell
14,511
-375
-3% -$116K 0.13% 142
2021
Q1 		$5.2M Buy
14,886
+7,978
+115% +$3.41M 0.17% 129
2020
Q4 		$3.53M Sell
6,908
-9,436
-58% -$3.78M 0.12% 130
2020
Q3 		$4.29M Hold
16,344
– – 0.19% 111
2020
Q2 		$8.93M Buy
16,344
+293
+2% +$132K 0.42% 83
2020
Q1 		$5.06M Buy
+16,051
New +$5.02M 0.32% 100

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's PASG Position: Q3 2021 in Review

Emerald Mutual Fund Advisers Trust sold out of Passage Bio (PASG) in Q3 2021, closing a stake of 14,511 shares — an estimated $3.84M sold.

Emerald Mutual Fund Advisers Trust first reported a position in PASG in Q1 2020 and held it in 6 quarters. The position peaked at $8.93M in Q2 2020. 101 funds tracked by Wall St. Rank hold PASG as of Q3 2021.

  • Emerald Mutual Fund Advisers Trust reported no remaining Passage Bio position as of Q3 2021 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 14,511 Passage Bio shares in Q3 2021, an estimated $3.84M.
  • Emerald Mutual Fund Advisers Trust first reported a position in Passage Bio in Q1 2020 and held it in 6 quarters.
  • Emerald Mutual Fund Advisers Trust's Passage Bio position peaked at $8.93M in Q2 2020.
  • 101 funds tracked by Wall St. Rank held Passage Bio as of Q3 2021.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q3 2021, filed 28 Oct 2021.